Rh/ Vulvovaginitis Flashcards

1
Q

Rhesus Factor

general

A

Rhesus factor
Inherited lipoprotein on the surface of RBCs
Several Rh antigens - Rh (D)
Presence of Rh (D) = Rh +; Absence of Rh = Rh-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rh (D) Negative vs Positive

A

If mother AND father are Rh (D) positive = fetus will be Rh (D) +
No intervention required

If both mother AND father Rh (D) negative = fetus will be Rh (D) –
No intervention required

If mother is Rh (D) negative and father is Rh(D) positive -> Fetus can be Rh(D) positive
RhoGam protocol to prevention of maternal antibodies against fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1st pregnancy

A

In the first pregnancy
If the mother is Rh NEGATIVE and the baby is Rh POSITIVE,there is Rh incompatibility
The mother will create anti-Rh (D) antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2nd pregnancy
Complications for baby

A

In the second pregnancy
The mother’s IgG anti-Rh (D) antibodies will travel through the placenta and attack the baby (if this baby is also Rh POSITIVE - ie has the antigen on it’s RBCs)
Can lead to fetal hemolytic anemia, or in severe cases, hydrops fetalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rh Alloimmunization

A

Alloimmunization
An immune response when exposed to foreign antigens which stimulates production of immunoglobulin G (IgG) antibodies

Maternal Rh (D) Alloimmunization
Rh (D) negative mother exposed to Rh (D) positive fetal blood

Occurs during events where maternal/fetal blood can mix:
Miscarriage, therapeutic termination, ectopic pregnancy, antenatal bleeding, abdominal trauma
Procedures: chorionic villus sampling (CVS), amniocentesis, external cephalic version (ECV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Screening for Rh(D) in Pregnancy

A

First prenatal visit
All pregnant women should be screened for the ABO blood group & Rh (D) antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prevention of Rh(D) Alloimmunization

And when to do it

A

Anti-D immunoglobulin (Rhogam) injection
Administered to women exposed or at high risk of being exposed to Rh (D) + RBCs
Suppresses immune response and antibody formation
Dose: 300 µg IM injection
Protect against maternal alloimmunization from 15mL of fetal RBCs/ 30mL of fetal whole blood

Rhogam administration protocol
28 weeks: Administer to all patients, if Rh negative
40 weeks: If more than 12 weeks have elapsed since Rhogam administration, administer again
Postpartum: If infant Rh (D) +
Recommend 72 hours after delivery, however shown to be effective up to 28 days after delivery
Fetomaternal bleeding
As little as 0.1 ml of Rh+ cells can cause sensitization !

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Evaluation of Fetomaternal Hemorrhage

A

Rosette test
Positive

Kleihauer-Betke test (flow cytometry)
Measure amount of fetal hemoglobin transferred to maternal bloodstream
Aid in determination of number of vials of Rhogam administered
1 vial contains 300mcg which protects against 30 mL of whole fetal blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Maternal Rh (D) Alloimmunization

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hemolytic Disease of the Fetus & Newborn

A

HDFN or erythroblastosis fetalis
Destruction of RBCs of the fetus or neonate by maternal IgG antibodies

Clinical manifestations
Mild self-limiting (hyperbilirubinemia within first 24 hours of life, symptomatic anemia without circulatory collapse)

Severe (Hydrops Fetalis)
Skin edema, pleural or pericardial effusion or ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rh(D) Summary

A

Routine screening
ABO, Rh (D)

Rhogam Protocol
300mcg IM injection
28 weeks, postpartum & Fetomaternal hemorrhage

Fetomaternal hemorrhage evaluation
Kleihauer-Betke test

HDFN
Mild – severe manifestations
Primarily dependent on transportation of maternal antibody concentrations

Management of Rh Alloimmunized Women
Step 1: Determine Fetal Risk
Step 2: Follow Maternal Anti-D Titers
Step 3: Assess for Severe Anemia in Fetus
Step 4: Determine Obstetric & Delivery Plan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vulvovaginitis

general

A

Term used to describe an acuteinflammationof the vulva and vagina that results from disruption of the normal vaginal environment (flora)

Epidemiology
~75% of women will have at least 1 episode of vulvovaginitis in their lifetime

Etiology
Infectious
Bacterial vaginosis (BV)
Candida albicans
Trichomonas vaginalis
Non-infectious
Lichen simplex chronicus
Irritant contact dermatitis
Lichen sclerosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vaginal Flora & Pathogenesis of Vulvovaginitis

A

Stratified squamous epithelium of the vagina is rich in glycogen

Glycogen is metabolized to lactic acid byLactobacillus:
Creates an acidic environment (pH3.8-4.2)
Maintains the normal vaginal flora
Inhibits growth of pathogens

Vulvovaginitis results from a disruption of the vaginal flora
↓ or ↑estrogen levels
Alkalinization of the vaginalpH
Menstrual blood
Semen
Hygienic products (douching)
↓Lactobacillusfrom broad-spectrum antibiotic use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bacterial Vaginosis (BV)

A

Also referred to asGardnerella vaginalis (most common etiology)

Etiology & Pathophysiology
↓Lactobacillus →↑pH→overgrowth of anaerobic bacteria:
Gardnerella vaginalis
Non-spore forming, non-motile, gram-variablebacillus
Creates a biofilm that then allows other opportunistic bacteria to grow within the vagina
Produces vaginolysin,a pore-forming toxin affectinghuman cells

Anaerobic bacteria produce enzymes →break down vaginal peptides into amines, leading to:
Vaginal transudation (vaginal secretions)
Squamous epithelial cell exfoliation
Odor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BV

Risk Factors

A

Unprotectedsex
↑ Number of sexual partners
Other sexually transmitted infections (STIs)
Douching
Bathing in a bathtub (particularly bubble baths)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BV

Clin man

A

~50% ofpatientsare asymptomatic
Vaginal discharge
White-gray, thin, malodorous (fishy) secretion
More pronounced after sexual intercourse
Vaginal mucosa and cervical epithelium will appear normal
No pelvic pain
No cervical motion tenderness

17
Q

BV

Dx and labs

A

Higher than normal vaginal pH (> 4.5)
Saline wet mount
Clue cells (bacteriaadhering to epithelial cells)
Whiff-amine test
Presence of a fishy odor when 10% potassiumhydroxide (KOH) is added to a sample of vaginal discharge

Amsel Diagnostic Criteria (3 of 4 must be present)
Thin, white-gray discharge
VaginalsecretionpH> 4.5
Positive amine whiff test (fishy odor)
Presence of clue cells

18
Q

BV

Tx

A

Treatment is recommended for symptomatic patients only
Exception: Asymptomatic pregnant patients should be treated

30% of infections resolve without treatment

First-line
Metronidazole 500 mg one tablet PO twice daily for 7 days
Metronidazole 0.75% vaginal gel 5-gram applicator intravaginally once daily for five days
Safe to use in pregnancy

Alternative
Clindamycin 2% vaginal cream 5-grams of cream intravaginally once daily for seven days
Clindamycin 300 mg one tablet PO twice daily for 7 days
Safe to use in pregnancy

19
Q

Candidal Vaginitis

Etiology & Pathophysiology

A

Most often caused by the fungus Candida albicans (80%–92%), which is a normal part of the vaginal flora
Not necessarily associated with ↓Lactobacillus

↑ Estrogen levels → ↑ vaginal glycogen → favorable environment forCandidagrowth and adherence

20
Q

candida BV

Clinical Presentation

A

Vulvar and vaginal
Pruritis, burning, and irritation
Erythema andedema
Vaginal discharge
Thick, white, curd-like
No odor
Dyspareunia

21
Q

candida BV

Dx

A

Vaginal pH is normal
Wet mount with 10% KOH
Buddingyeast
Pseudohyphae
↑ WBCs
Clumps of epithelial cells

Negative “whiff” test
Vaginal culture (yeast)
When microscopy is unrevealing
Continued symptoms despite treatment

22
Q

candida

tx

A

Treatment options include oral or topical antifungals
Oral
Most convenient
Fluconazole 150 mg one tablet PO once

Topical
Preferred treatment during pregnancy
Clotrimazole
cream or vaginal suppository for 1-7 days
Miconazole vaginal suppository for 1-7 days

23
Q

Trichomoniasis

General

A

Most common non-viralsexually transmitted infection (~2.6 million cases yearly)

Causative agent
Trichomonas vaginalis
Flagellated protozoan
Frequently coexists with BV
Often associated with other STIs and can enhance transmission of HIV
Associated with adverse obstetric outcomes
Premature rupture of the membranes
Preterm delivery
Delivery of a low-birth weight infant
Risk factors
Unprotectedsex
Multiplesexpartners

24
Q

Trich

Patho

A

Infection is associated with ↓Lactobacillusand ↑ vaginalpH
T. vaginalis adheres to vaginal epithelial cells
Releases cytotoxic substances → destroys epithelial cells
Binds hostplasma proteins→ evades the hostimmune system
Releases chemotactic substances → attract polymorphonuclear leukocytes (PMNs)
May also disrupt the vaginal flora

25
Q

trich

♀ Clinical Features

A

Acute infection
Vaginal discharge
Frothy yellow-green discharge
Scant to copious
Malodorous (fishy)
Vaginal pruritus and irritation
Dysuria
Dyspareunia
Strawberry” redcervix and red “strawberry” spots on the vaginal walls
Postcoital bleeding may also occur

Chronic infection
Signs and symptoms as above, but milder
Pruritus and dyspareunia with scant vaginal secretions

26
Q

Trich

♂ Clinical Features

A

> 75% of cases are asymptomatic and transient (spontaneous resolution within 10 days)Symptoms
Clear or mucopurulent urethral discharge
Dysuria
Urge to urinate frequently
Burning or pruritus in the penis after sexual intercourse

27
Q

trich

Dx

A

Wet mount of vaginal secretions
Motile, flagellated, ovoidprotozoans
Presence of PMNs
pH> 4.5
Positive Whiff-amine test

Nucleic acid amplification test(NAAT)
Accepted gold standard

Very sensitive and specific
Detects and amplifiesRNAfromT. vaginalis

Concurrentinfections should be ruled out
Testing for BV, chlamydia and gonorrhea

28
Q

Trich

Tx

A

First-line
Women
Metronidazole 500 mg one tablet PO twice daily for 7 days
Preferred treatment in pregnancy
Men
Metronidazole 500 mg four tablets PO once

Alternative
Tinidazole2 g orally in a single dose
Sexual partner(s) require treatment
Abstain from intercourse for 7 days following completion of therapy

29
Q

Trich

screening

A

CDC screening recommendations for Trichomonas

All HIV-infected women annually and at the initial prenatal visits

All women with new or multiple partners

Women with a history of sexually transmitted infections

Screening for men is not recommended

30
Q
A